NCT05657210 is a clinical trial of Mutation in Colorectal Cancer, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT05657210?

NCT05657210 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT05657210?

Interventions in NCT05657210: Mutation.

What condition does NCT05657210 study?

NCT05657210 studies Colorectal Cancer.

Is NCT05657210 still recruiting?

NCT05657210 is currently completed. Last updated 20 December 2022.

Last reviewed 2022-12-20 · How we verify

NCT05657210

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

Completed Last updated 20 December 2022

What this trial tests

trial testing Mutation in Colorectal Cancer in 2,203 participants. Completed in 31 December 2021.

Timeline

1 January 2009

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,203
Start date	1 January 2009
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across South Korea

Drugs / interventions tested

Mutation

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

Seoul National University Bundang Hospital

Who can join

Eligibility, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective study reviewed 3,144 patients who underwent surgery for colorectal cancer. This study was designed to comprehend the clinicopathological characteristics associated with individual codon-specific KRAS mutations in colorectal cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Different oncological features of colorectal cancer codon-specific <i>KRAS</i> mutations: Not codon 13 but codon 12 have prognostic value.
Ahn HM, Kim DW, Oh HJ, Kim HK, et al · · 2023 · cited 11× · PMID 37701134 · DOI 10.3748/wjg.v29.i32.4883

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05657210 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 20 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05657210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing